This [trial] led to the FDAs approval in June 2021 of a once-weekly injectable GLP-1 under the brand name Wegovy [for weight management in individuals with overweight and obesity who have at least one weight-related condition], Dr
Print this page or save it as a PDF for quick reference at your workstation
10.1002/jcp.1041380213
Svahn SL, Vremo L, Gabrielsson BG, Peris E, Nookaew I, Grahnemo L, et al
DSIP also demonstrates effects on the opioid system in the brain
The consensus process also identified areas in need of further research, such as the development and evaluation of diagnostic and outcome questionnaires, agreement of threshold glycaemia levels for reliable diagnosis, evaluation of the therapeutic efficacy of acarbose for symptoms of early dumping syndrome and assessment of the relative efficacy of short-acting versus long-acting somatostatin analogues